Successful treatment with rituximab of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation

J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):e2-4. doi: 10.1097/MPG.0b013e31826f2786.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Child, Preschool
  • Epstein-Barr Virus Infections / drug therapy*
  • Epstein-Barr Virus Infections / virology
  • Female
  • Herpesvirus 4, Human*
  • Humans
  • Immunologic Factors / therapeutic use
  • Leiomyosarcoma / drug therapy*
  • Leiomyosarcoma / etiology
  • Leiomyosarcoma / virology
  • Liver Transplantation*
  • Lymphoproliferative Disorders / drug therapy*
  • Lymphoproliferative Disorders / etiology
  • Lymphoproliferative Disorders / virology
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / virology
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab